Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shockwave therapy may ease stubborn achilles pain

NCT ID NCT07685509

Symptom relief Sponsor: Vastra Gotaland Region Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether adding shockwave therapy to a tailored exercise program reduces pain and improves function in people with Achilles tendon pain. Two hundred adults with pain in the mid-portion or insertion of the tendon will be randomly assigned to exercise alone or exercise plus six shockwave sessions. The trial also examines changes in tendon blood flow and immune cells, aiming to understand why some cases persist.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
radial shockwave therapy
What this could lead to
If it works, this could provide a better treatment option for persistent Achilles tendon pain, potentially reducing the need for surgery.
What could go wrong
This is a mid-sized trial, and the added benefit of shockwave over exercise alone may be small or absent. Results may not apply to all types of tendon pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women and men over 18 years of age who seek care for load-related pain in the midportion of the Achilles tendon or at the Achilles tendon insertion at a Physiotherapy Clinic in Primary Care, at the Physiotherapy Department at Sahlgrenska University Hospital/Mölndal, or at the Orthopedic Department at Sahlgrenska University Hospital/Mölndal. * Symptoms must have been present for one month or longer. * Symptoms may be present in one or both Achilles tendons. Exclusion Criteria: * Unwillingness to receive shockwave therapy. * Previous shockwave therapy for Achilles tendon pain within the past year. * Neurological disease, significant cardiac conditions, increased bleeding tendency, treatment with anticoagulant medication, pregnancy, or presence of a tumor in the foot. * Corticosteroid injection in the foot within the past six months. * Reduced sensation, acute inflammation, or any wound around the heel. * Inability to understand or speak Swedish.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Achilles tendinopathy (AT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Achilles bursitis disease of the tendon Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Achilles tendinopathy (AT) Achilles tendon Achilles tendon pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.